Article Information
History
- July 9, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Mieradilijiang Abudupataer1,
- Shichao Zhu1,
- Shiqiang Yan2,
- Kehua Xu2,
- Jingjing Zhang2,
- Shaman Luo2,3,
- Wenrui Ma1,
- Md. Fazle Alam2,3,
- Yuyi Tang2,
- Hui Huang2,
- Nan Chen1,
- Li Wang2,
- Guoquan Yan2,
- Jun Li1,
- Hao Lai1,
- Chunsheng Wang1,#,
- Kai Zhu1,# and
- Weijia Zhang1,2,3,#
- 1Department of Cardiac Surgery and Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai 200032, China
- 2Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China
- 3The State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai 200438, China
- ↵#To whom correspondence should be addressed: Kai Zhu, Chunsheng Wang & Weijia Zhang, Emails
: zhu.kai1{at}zs-hospital.sh.cn; wangchunsheng{at}fudan.edu.cn; weijiazhang{at}fudan.edu.cn
Posted July 09, 2021.
Aorta-on-a-chip reveals impaired mitochondrial dynamics as a therapeutic target for aortic aneurysm in bicuspid aortic valve disease
